Biological preparation method of (3R, 5R)-6-cyano-3,5-dyhydroxytert-butylhexanoate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HUANGGANG HUAYANG PHARMA
- Publication Date
- 2014-04-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of biopharmaceuticals, and in particular relates to a biological preparation method of atorvastatin intermediate (3R,5R)-6-cyano-3,5-dihydroxyhexanoic acid tert-butyl ester. Background technique
[0002] Statins reduce low-density lipoprotein cholesterol (LDL-C) levels by inhibiting HMG-CoA reductase in the cholesterol synthesis pathway, and have a good effect on hyperlipidemia mainly caused by elevated cholesterol. Widely used lipid-regulating drugs. Atorvastatin (Atorvastatin) has become a new third-generation, fully synthetic, highly purified, and highly selective HMG-CoA reductase inhibitor due to its advantages of rapid onset of action, strong lipid-lowering effect, and long action time. The most promising statin drugs in the market. And (3R,5R)-6-cyano-3,5-dihydroxyhexanoic acid tert-butyl ester is the most important intermediate of atorvastatin, therefore, the development of (3R,5R)-6-cyano-3 , The synthetic...